Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000428 | DNA-directed RNA polymerase complex | 4 | 11 |
GO:0005634 | nucleus | 5 | 2 |
GO:0005665 | RNA polymerase II, core complex | 4 | 2 |
GO:0005666 | RNA polymerase III complex | 4 | 2 |
GO:0005736 | RNA polymerase I complex | 4 | 2 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0030880 | RNA polymerase complex | 3 | 11 |
GO:0031974 | membrane-enclosed lumen | 2 | 2 |
GO:0031981 | nuclear lumen | 5 | 2 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 2 |
GO:0032991 | protein-containing complex | 1 | 11 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0043233 | organelle lumen | 3 | 2 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 3 | 9 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 4 | 11 |
GO:0070013 | intracellular organelle lumen | 4 | 2 |
GO:0097014 | ciliary plasm | 5 | 2 |
GO:0099568 | cytoplasmic region | 3 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0140513 | nuclear protein-containing complex | 2 | 9 |
GO:0140535 | intracellular protein-containing complex | 2 | 11 |
GO:1902494 | catalytic complex | 2 | 11 |
GO:1990234 | transferase complex | 3 | 11 |
Related structures:
AlphaFold database: Q4QDW3
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 11 |
GO:0006351 | DNA-templated transcription | 7 | 11 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009058 | biosynthetic process | 2 | 11 |
GO:0009059 | macromolecule biosynthetic process | 4 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016070 | RNA metabolic process | 5 | 11 |
GO:0018130 | heterocycle biosynthetic process | 4 | 11 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 11 |
GO:0032774 | RNA biosynthetic process | 5 | 11 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 11 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0044249 | cellular biosynthetic process | 3 | 11 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 11 |
GO:0046483 | heterocycle metabolic process | 3 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:0090304 | nucleic acid metabolic process | 4 | 11 |
GO:0097659 | nucleic acid-templated transcription | 6 | 11 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 11 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 11 |
GO:1901576 | organic substance biosynthetic process | 3 | 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0003677 | DNA binding | 4 | 11 |
GO:0003824 | catalytic activity | 1 | 11 |
GO:0003899 | DNA-directed 5'-3' RNA polymerase activity | 6 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0016740 | transferase activity | 2 | 11 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 11 |
GO:0016779 | nucleotidyltransferase activity | 4 | 11 |
GO:0034062 | 5'-3' RNA polymerase activity | 5 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:0097747 | RNA polymerase activity | 4 | 11 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 11 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 95 | 99 | PF00656 | 0.561 |
CLV_NRD_NRD_1 | 116 | 118 | PF00675 | 0.538 |
CLV_NRD_NRD_1 | 139 | 141 | PF00675 | 0.641 |
CLV_NRD_NRD_1 | 294 | 296 | PF00675 | 0.344 |
CLV_NRD_NRD_1 | 87 | 89 | PF00675 | 0.624 |
CLV_PCSK_KEX2_1 | 116 | 118 | PF00082 | 0.496 |
CLV_PCSK_KEX2_1 | 139 | 141 | PF00082 | 0.612 |
CLV_PCSK_KEX2_1 | 87 | 89 | PF00082 | 0.624 |
CLV_PCSK_PC7_1 | 83 | 89 | PF00082 | 0.544 |
CLV_PCSK_SKI1_1 | 139 | 143 | PF00082 | 0.537 |
CLV_PCSK_SKI1_1 | 190 | 194 | PF00082 | 0.563 |
CLV_PCSK_SKI1_1 | 217 | 221 | PF00082 | 0.465 |
CLV_PCSK_SKI1_1 | 88 | 92 | PF00082 | 0.692 |
DOC_MAPK_gen_1 | 190 | 200 | PF00069 | 0.424 |
DOC_MAPK_gen_1 | 220 | 229 | PF00069 | 0.483 |
DOC_MAPK_MEF2A_6 | 193 | 200 | PF00069 | 0.384 |
DOC_MAPK_MEF2A_6 | 232 | 239 | PF00069 | 0.574 |
DOC_MAPK_RevD_3 | 281 | 296 | PF00069 | 0.491 |
DOC_USP7_MATH_1 | 68 | 72 | PF00917 | 0.577 |
DOC_USP7_UBL2_3 | 186 | 190 | PF12436 | 0.598 |
DOC_USP7_UBL2_3 | 205 | 209 | PF12436 | 0.528 |
DOC_USP7_UBL2_3 | 217 | 221 | PF12436 | 0.405 |
DOC_WW_Pin1_4 | 200 | 205 | PF00397 | 0.448 |
DOC_WW_Pin1_4 | 281 | 286 | PF00397 | 0.475 |
DOC_WW_Pin1_4 | 61 | 66 | PF00397 | 0.443 |
LIG_14-3-3_CanoR_1 | 131 | 137 | PF00244 | 0.479 |
LIG_14-3-3_CanoR_1 | 139 | 144 | PF00244 | 0.645 |
LIG_14-3-3_CanoR_1 | 14 | 20 | PF00244 | 0.294 |
LIG_APCC_ABBA_1 | 259 | 264 | PF00400 | 0.343 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.491 |
LIG_deltaCOP1_diTrp_1 | 53 | 61 | PF00928 | 0.389 |
LIG_FHA_1 | 131 | 137 | PF00498 | 0.446 |
LIG_FHA_1 | 228 | 234 | PF00498 | 0.473 |
LIG_FHA_2 | 250 | 256 | PF00498 | 0.496 |
LIG_FHA_2 | 282 | 288 | PF00498 | 0.534 |
LIG_Integrin_RGD_1 | 77 | 79 | PF01839 | 0.474 |
LIG_LIR_Gen_1 | 122 | 130 | PF02991 | 0.458 |
LIG_LIR_Nem_3 | 332 | 338 | PF02991 | 0.441 |
LIG_Pex14_2 | 57 | 61 | PF04695 | 0.384 |
LIG_SH2_NCK_1 | 105 | 109 | PF00017 | 0.435 |
LIG_SH2_NCK_1 | 176 | 180 | PF00017 | 0.509 |
LIG_SH2_STAP1 | 105 | 109 | PF00017 | 0.575 |
LIG_SH2_STAP1 | 176 | 180 | PF00017 | 0.509 |
LIG_SH2_STAT5 | 28 | 31 | PF00017 | 0.391 |
LIG_SH2_STAT5 | 314 | 317 | PF00017 | 0.456 |
LIG_SH3_3 | 37 | 43 | PF00018 | 0.453 |
LIG_SH3_3 | 59 | 65 | PF00018 | 0.494 |
LIG_SUMO_SIM_par_1 | 224 | 230 | PF11976 | 0.352 |
LIG_TRAF2_1 | 3 | 6 | PF00917 | 0.436 |
LIG_TYR_ITIM | 312 | 317 | PF00017 | 0.440 |
LIG_WRC_WIRS_1 | 211 | 216 | PF05994 | 0.405 |
MOD_CDC14_SPxK_1 | 64 | 67 | PF00782 | 0.415 |
MOD_CDK_SPK_2 | 200 | 205 | PF00069 | 0.441 |
MOD_CDK_SPxK_1 | 61 | 67 | PF00069 | 0.479 |
MOD_CK1_1 | 146 | 152 | PF00069 | 0.681 |
MOD_CK1_1 | 81 | 87 | PF00069 | 0.788 |
MOD_CK2_1 | 204 | 210 | PF00069 | 0.434 |
MOD_CK2_1 | 249 | 255 | PF00069 | 0.488 |
MOD_CK2_1 | 281 | 287 | PF00069 | 0.465 |
MOD_GlcNHglycan | 158 | 161 | PF01048 | 0.792 |
MOD_GlcNHglycan | 200 | 203 | PF01048 | 0.348 |
MOD_GlcNHglycan | 243 | 247 | PF01048 | 0.485 |
MOD_GlcNHglycan | 33 | 36 | PF01048 | 0.446 |
MOD_GlcNHglycan | 331 | 334 | PF01048 | 0.253 |
MOD_GlcNHglycan | 83 | 86 | PF01048 | 0.731 |
MOD_GSK3_1 | 139 | 146 | PF00069 | 0.639 |
MOD_GSK3_1 | 200 | 207 | PF00069 | 0.418 |
MOD_GSK3_1 | 329 | 336 | PF00069 | 0.501 |
MOD_NEK2_1 | 130 | 135 | PF00069 | 0.448 |
MOD_NEK2_1 | 143 | 148 | PF00069 | 0.721 |
MOD_NEK2_2 | 204 | 209 | PF00069 | 0.517 |
MOD_NEK2_2 | 68 | 73 | PF00069 | 0.363 |
MOD_PKA_1 | 139 | 145 | PF00069 | 0.614 |
MOD_PKA_1 | 221 | 227 | PF00069 | 0.461 |
MOD_PKA_2 | 130 | 136 | PF00069 | 0.495 |
MOD_PKA_2 | 139 | 145 | PF00069 | 0.717 |
MOD_PKA_2 | 318 | 324 | PF00069 | 0.440 |
MOD_Plk_2-3 | 210 | 216 | PF00069 | 0.404 |
MOD_Plk_4 | 143 | 149 | PF00069 | 0.764 |
MOD_Plk_4 | 15 | 21 | PF00069 | 0.359 |
MOD_Plk_4 | 222 | 228 | PF00069 | 0.436 |
MOD_Plk_4 | 318 | 324 | PF00069 | 0.440 |
MOD_Plk_4 | 333 | 339 | PF00069 | 0.534 |
MOD_ProDKin_1 | 200 | 206 | PF00069 | 0.442 |
MOD_ProDKin_1 | 281 | 287 | PF00069 | 0.475 |
MOD_ProDKin_1 | 61 | 67 | PF00069 | 0.451 |
MOD_SUMO_for_1 | 90 | 93 | PF00179 | 0.796 |
MOD_SUMO_rev_2 | 2 | 10 | PF00179 | 0.405 |
MOD_SUMO_rev_2 | 289 | 297 | PF00179 | 0.527 |
TRG_DiLeu_BaEn_2 | 286 | 292 | PF01217 | 0.496 |
TRG_ENDOCYTIC_2 | 314 | 317 | PF00928 | 0.440 |
TRG_ENDOCYTIC_2 | 338 | 341 | PF00928 | 0.440 |
TRG_ER_diArg_1 | 115 | 117 | PF00400 | 0.568 |
TRG_ER_diArg_1 | 138 | 140 | PF00400 | 0.560 |
TRG_ER_diArg_1 | 86 | 88 | PF00400 | 0.670 |
TRG_NLS_MonoExtN_4 | 217 | 224 | PF00514 | 0.486 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P8I4 | Leptomonas seymouri | 68% | 100% |
A0A1X0P763 | Trypanosomatidae | 44% | 100% |
A0A3R7KXJ2 | Trypanosoma rangeli | 45% | 100% |
A0A3S5H734 | Leishmania donovani | 94% | 100% |
A4H9J0 | Leishmania braziliensis | 78% | 100% |
A4HXV3 | Leishmania infantum | 94% | 100% |
C9ZZV0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 100% |
E9ARL6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
V5B6J4 | Trypanosoma cruzi | 44% | 100% |